These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9160406)

  • 41. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
    Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
    Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Klin Med (Mosk); 1988 Mar; 66(3):45-7. PubMed ID: 3392922
    [No Abstract]   [Full Text] [Related]  

  • 43. The interaction of inhaled toxicants with respiratory tract clearance mechanisms.
    Schlesinger RB
    Crit Rev Toxicol; 1990; 20(4):257-86. PubMed ID: 2178627
    [No Abstract]   [Full Text] [Related]  

  • 44. [Expectoration disorders in patients with chronic obstructive lung diseases].
    Solopov VN; Lunichkina IV
    Klin Med (Mosk); 1990 May; 68(5):60-5. PubMed ID: 2398723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.
    Ge LT; Liu YN; Lin XX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
    Int Immunopharmacol; 2016 Apr; 33():90-8. PubMed ID: 26881857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [External respiratory function in combined therapy of chronic nonspecific lung diseases and the bronchospasm syndrome].
    Usenko IuD; Babich GG; Petrova IE; Filippova ES
    Vrach Delo; 1981 May; (5):19-21. PubMed ID: 6789554
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.
    Begrow F; Böckenholt C; Ehmen M; Wittig T; Verspohl EJ
    Adv Ther; 2012 Apr; 29(4):350-8. PubMed ID: 22477544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expectorant and liquescent preparations in the therapy of bronchial asthma and nonspecific lung diseases and their prevention].
    Komarov FI; Daniliak IG; Guliaeva FE; Mindlina GI; Zhukova AV
    Klin Med (Mosk); 1980 Apr; 58(4):19-24. PubMed ID: 6991798
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rational asthma drug therapy].
    Fischer JF; Meister W; Mohorn M
    Z Arztl Fortbild (Jena); 1983; 77(7):283-90. PubMed ID: 6407218
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pulmonary mucociliary clearance. Clinical aspects and possibilities for intervention].
    Mortensen J; Groth S; Lange P
    Ugeskr Laeger; 1988 Jul; 150(29):1775-8. PubMed ID: 3420694
    [No Abstract]   [Full Text] [Related]  

  • 51. [Differential use of bronchodilator agents in acute pneumonia].
    Samartsev GA; Viaznikova GA
    Sov Med; 1977 Sep; (9):24-8. PubMed ID: 929295
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bronchopulmonary diseases in advanced age. Therapy using Expectorans Solucampher].
    Boecker M
    ZFA (Stuttgart); 1979 Feb; 55(6):400-2. PubMed ID: 419831
    [No Abstract]   [Full Text] [Related]  

  • 53. [Inhalation therapy at the bed-side. Surgical and anesthesiological problems].
    Rügheimer E; Grimm H
    Med Klin; 1971 Jun; 66(26):955-9. PubMed ID: 5089352
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bronchodilator therapy in hypersecretive bronchipulmonary diseases].
    Bariffi F; Chianca P; Bocchino M
    Arch Monaldi; 1977; 32(1-2):40-57. PubMed ID: 612297
    [No Abstract]   [Full Text] [Related]  

  • 55. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical experiences in parenteral treatment with a broncho-secretolytic agent].
    Marquardt R
    Med Monatsschr; 1966 Jul; 20(7):322-4. PubMed ID: 5927494
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effectiveness of pharmacologic and non-pharmacologic methods of restoring bronchial patency].
    Lunichkina IV; Solopov VN
    Klin Med (Mosk); 1989 Jun; 67(6):109-11. PubMed ID: 2779144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Respiratory preparation for surgical intervention. General principles and methods].
    Scherpereel P
    Anesth Analg (Paris); 1978; 35(4):625-34. PubMed ID: 727538
    [No Abstract]   [Full Text] [Related]  

  • 59. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bronchospasm, pulmonary infiltration and eosinophilia rapid response to prednisone.
    McKenna TJ; Golden EN
    Ir J Med Sci; 1973 Jul; 142(4):162-5. PubMed ID: 4726288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.